Anavex Life Sciences
AVXL
#8578
Rank
HK$1.87 B
Marketcap
HK$20.23
Share price
1.57%
Change (1 day)
-72.29%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): -HK$4.21

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -HK$4.23. a decrease over its 2024 EPS that were of -HK$4.08.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025-HK$4.233.85%
2024-HK$4.08-13.33%
2023-HK$4.70-3.23%
2022-HK$4.8614.81%
2021-HK$4.2320%
2020-HK$3.53-16.67%
2019-HK$4.2338.46%
2018-HK$3.0618.18%
2017-HK$2.59-21.43%
2016-HK$3.29-35.38%
2015-HK$5.10-36.27%
2014-HK$8.00112.5%
2013-HK$3.76-58.62%
2012-HK$9.10-0%
2011-HK$9.10-29.27%
2010-HK$12.8651.85%
2009-HK$8.47-0%
2008-HK$8.47237.5%
2007-HK$2.51
2006N/A-100%
2005-HK$0.31499.97%
2004-HK$0.05227

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
HK$49.40-1,266.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
HK$3.53-183.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-HK$234.43 5,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$9.80-331.48%๐Ÿ‡บ๐Ÿ‡ธ USA